In this case report, the patient was initially diagnosed with triple-negative breast cancer, but a reevaluation of the metastatic disease showed her to be HER-2-positive by FISH, and she was diagnosed with HER-2-positive metastatic breast cancer. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.